常州市存仁生物工程有限公司

新聞

聯(lián)系我們

電話(huà): +86-519-85788828
傳真: +86-519-89960117
E-mail: sales@chemrenpharm.com
地址: 江蘇省常州市新北區百丈工業(yè)園
QQ: 2500035664

NSC 74859

Description of:NSC 74859
S31-201 (NSC 74859) is a chemical probe inhibitor of Stat3 activity, which was identified from the National Cancer Ins...

Description of:AZD1480
AZD1480 suppresses the growth of human solid tumor xenografts harboring persistent Stat3 activity. [1] AZD1480 inhibited...

Description of:TG101348
TG-101348 is a potent, highly selective and ATP- competitive JAK2 inhibitor with an IC50 of 3 nM for JAK2 and JAK2 V617...

Molecular Weight 509.67 ...

Description of:CYT387
CYT387 has significantly less activity against other kinases, including JAK3 (IC50=0.16 μM). CYT387 inhibits growth of...

Description of:LY2784544
LY2784544 is a small molecule selective mutant JAK2 kinase inhibitor with an IC50 of 68 nM.
Theoretical analy...

Description of:Ruxolitinib(INCB018424)魯索替尼
INCB018424 (Ruxolitinib) is an orally bioavailable JAK inhibitor .(IC50 values for JAK1, JAK2 and JA...

Description of:Tasocitinib(CP690550)
CP690550(Tasocitinib) treatment of murine factor-dependent cell Patersen-erythropoietin receptor (FDCP-Epo...

總數: 38 頁(yè): 4 / 4 首頁(yè) ←上一頁(yè) 下一頁(yè)→ 末頁(yè)